HAS1 and metabolic dysfunction-associated steatotic liver disease: In visceral adipose tissue (VAT) from individuals with obesity, HAS1 is selectively upregulated, while HAS2 and HAS3 remain largely unchanged, suggesting that HAS1-driven HA synthesis in adipose tissue may contribute to systemic inflammation and the development of MASLD [25].